Announcement Featured | NIO intends to be re-listed on the Singapore Stock Exchange; the clover divalent COVID-19 vaccine candidate has been shown to have a neutralizing effect on the Amicoreon strain

A selection of blockbuster announcements

1. $NIO-SW(09866.HK)$: Intends to be listed on the Singapore Stock Exchange for the second time

NIO announced that it intends to be listed on the Singapore Stock Exchange for the second time. After listing on the Main Board of the SGX, the shares listed on the Main Board of the SGX will be fully interchangeable with the Adsary Receipts listed on the New York Stock Exchange, and the American Depositary Receipts will remain primarily listed on the New York Stock Exchange.

2. $Clover-B (02197.HK)$: The bivalent COVID-19 vaccine candidate shows a broad-spectrum neutralizing effect on Omilon and other noteworthy variants

Clover-B Announcement The Company is pleased to announce positive new data from the preclinical study of clover bivalent COVID-19 candidate vaccine, which combines trimer spike protein antigens from the original COVID-19 strain and the Omiljung variant. In preclinical studies, it was found that the bivalent candidate vaccine as a basic vaccine and booster injection induced a broad-spectrum neutralization effect on all worthy variants of concern, including Omilon. The manuscript "Cross-protection of noteworthy variants by the bivalent S-trimer COVID-19 vaccine" has been preprinted on bioRxiv, a bioprint server, and will be submitted to peer-reviewed scientific journals.

3. $BeiGene (06160.HK) lost $434 million in the first quarter, product revenue increased 146% to $262 million, and R&D expenses were $390 million during the quarter

BeiGene state announced that it recorded a net loss of $434 million in the first quarter of 2022, compared to a net income of $66.5 million in the same period last year, due to a decrease in cooperative income. Product revenue of $261.6 million, up 146% from $106.1 million in the year-ago quarter, and baiyueze's global sales in the first quarter of 2022 increased by 372% compared to the same period last year, thanks to sales growth in China and the United States. During the quarter, R&D expenses increased to $390 million from $321 million in the year-ago quarter, primarily due to increased headcount and increased investment in drug discovery and clinical development.

4. $Jinchuan International (02362.HK)$: MusonOI project oxide ore test back to take a key breakthrough

Jinchuan International announced that the Group's Mustonoi project in the Democratic Republic of the Congo has taken a key breakthrough in the test of oxidation ore. The Musonoi Project, one of the Group's key projects, is a super-large copper and cobalt mine with a total reserve of 606,000 tonnes of copper and 174,000 tonnes of cobalt. Since the start of construction of the Musonoi project, the mining construction project has progressed smoothly, and the main project construction and key lines have exceeded the schedule. The relevant projects of the recovery of the oxide ore in the upper part of the ore body have been fully completed, and the oxide ore test recovery has made good progress. 3,455 tonnes of oxide ore have been mined between 1 January 2022 and 3 May 2022. Through the laboratory analysis of this batch of ore samples, the cobalt grade is close to 2%. With the smooth progress of the trial recovery of the oxide ore in the 80-meter layer and the rapid advancement of the 140-meter layer oxide mine recovery project, it marks that the construction of the Mustonoi project has entered the parallel stage of infrastructure construction and production, and has taken a key step in the exploration of the new model of "building with mineral nutrition, building fast and producing quickly".

5. $Times Electric (03898.HK)$: Shareholder CRRC Hong Kong Capital has increased its shareholding in the company by 1.45%

Times Electric (03898) announced that on April 29, 2022, the Company received the "Progress Letter of Share Increase" from its shareholder, CRRC Hong Kong Capital Management Co., Ltd., informing CRRC Hong Kong Capital that from January 11, 2022 to April 29, 2022, it had increased its holding of 20.5214 million H shares of the company through the trading system of the Hong Kong Stock Exchange, accounting for about 1.45% of the total share capital of the company.

6. $Yuexiu Real Estate (00123.HK)$: Spent 2.736 billion yuan to successfully bid for a land plot in Nansha District, Guangzhou

Yuexiu Real Estate announced that on May 5, 2022, through Guangzhou Urban Construction Development Nansha Real Estate Co., Ltd., a subsidiary with a 95.48% interest, the Company successfully bid for the 2022 NJY-3 plot of Meishan Sugar Factory West 2022 NJY-3 in Nansha District, Guangzhou city through a public listing for RMB2.736 billion.

Significant matters

NIO (09866): Proposed to be listed on the Singapore Stock Exchange for the second time

CSPC Pharmaceutical Group (01093): "Donepezil Hydrochloride Tablets" was approved for drug registration

Jinchuan International (02362): The Musonoi project has made a key breakthrough in the test of oxide ore

Huineng Group (01539): Established a green property development business division and invested in data center project companies

Sun Hung Kai Company (00086): Subsidiary proposes to establish a fund and subscribe for US$100 million of fund shares by transferring the existing credit portfolio and cash payment

Yuexiu Real Estate (00123): Subsidiary bid for Land parcel in Nansha, Guangzhou for RMB2.736 billion

WuXi AppTec (02359): Approximately 3,786,100 restricted A shares will be listed and traded from May 12

Cinda Biotech (01801): Terminated the cooperation agreement with Coherus to reclaim IBI-305's commercialization interests in the United States and Canada

Chinese Shou (02628): Preliminarily recognized by the SEC as a board-certified issuer under the Accountability Act

Shanghai Industrial Holdings (00363): Shanghai Municipal Transportation Commission plans to implement the G50 Shanghai-Chongqing Expressway (Shanghai Section) reconstruction and expansion project

Financial report data

Cifi Holding Group (00884): Cumulative contract sales in the first four months of the year were about 38.84 billion yuan

Budweiser Asia Pacific (01876): Normalized profit attributable to shareholders in the first quarter of $304 million, up 28.8% year-over-year

Sunac China (01918): Contracted sales of about 13.57 billion yuan in April

Midea Real Estate (03990): Contract sales in the first four months of about 24.60 billion yuan, down 53.64% year-on-year

Jianye Real Estate (00832): Property contract sales in April were 2.63 billion yuan

Zhongyuan Jianye (09982): Contract sales of projects under management in April were 1.798 billion yuan

Xiehe New Energy (00182): Solar equity power generation reached 66.02GWh in April, an increase of 219.25% year-on-year

Jinchuan International (02362): Sales of copper and cobalt increased by 6% and 22% respectively in the first quarter

Melco International Development (00200): Released Melco Boya Entertainment's first quarter results with a net loss of approximately $222 million, narrowing by 20.06% year-on-year

BeiGene (06160): A loss of $434 million in the first quarter, product revenue increased 146% to $262 million and research and development expenses were $390 million during the quarter

China Biotechnology Services (08037): Net profit in the first quarter is expected to be no less than HK$34 million, an increase of more than 17.69 times year-on-year

Kanglong Huacheng (03759): Proposed final interest rate of 4.5 yuan per 10 shares

Buyback cancellation

Dreamland (01119): Has launched a HK$200 million repurchase program, with a cumulative repurchase of 4.154 million shares

AIA (01299): Invested HK$163 million to repurchase 2,114,600 shares on May 5

HSBC Holdings (00005): Repurchased 1.6 million shares on May 5

Melco International Development (00200): Melco Boya Entertainment spent $79 million to repurchase approximately 27.7433 million shares

Change of shareholding

Red Star Macalline (01528): Acquired 936,900 shares of the company by some executives

Bank of Chongqing (01963): The total amount of increase in the shareholding plan has exceeded half The cumulative increase in the number of shares increased by the main body of the increase was 3.1382 million shares

Times Electric (03898): Shareholder CRRC Hong Kong Capital increased its shareholding by 1.45%

Edit/irisz

Risk Warning: The views of the authors or guests shown above have their own specific positions, and investment decisions need to be based on independent thinking. Futu will endeavour, but cannot guarantee, the accuracy and reliability of the above and will not be liable for any loss or damage arising from any inaccuracies or omissions.